Narcan, the nasal spray that reverses an opioid overdose, is now available without prescription. But how easy is it to get? In this quick take, Rice University students and fellow Katharine Neill Harris investigate the reality of over-the-counter (OTC) access to the live-saving drug naloxone.

Legalizing recreational marijuana was intended to remedy the racially disparate effects of cannabis prohibition. But new research from our experts finds persistent racial disparities in the legal system’s practice of mandating treatment for cannabis use.

This week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health.

Abstract

Purpose – Despite the progression of recreational cannabis legalization, the legal system remains the largest…

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.

The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.

In the United States, drug overdose deaths are on the rise. In 2022, CDC researchers reported that 110,236 people died from an overdose in a single 12-month period, setting a new record. Synthetic opioid overdose deaths, primarily due to fentanyl, increased nearly 7.5-fold from 2015 to 2021. In Texas, the number of fentanyl-related deaths rose dramatically — from 883 deaths in 2020 to 1,672 deaths in 2021. While Republican lawmakers in Texas have previously opposed harm reduction policies, many have signaled a desire to take policy action to combat the crisis in the 2023 legislative session.

On October 12, 2022, Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy, testified before the Texas House of Representatives Interim Study Committee on Criminal Justice Reform. Her written testimony addresses the committee's inquiry into policies and penalties relating to drug offenses.

There have been promising developments in recent years in the fight to reduce overdose deaths. But barriers to drug checking and other overdose prevention tools remain throughout the country, writes fellow Katharine Neill Harris.